Bio-Rad Laboratories, Inc. BIO-B
389.98 USD 0.00 (+0.00%)
Nov 9, 2026, 11:50 AM EST
389.98 Day range 389.98
244.54 52-week range 389.98
- YTD
- +25.52%
- 1 year
- +27.69%
News
seekingalpha.com Bio-Rad Laboratories: Macroeconomic Uncertainty And A Limited Growth Potential Give Pause The U.S. Government plans to cut the annual budget allocated to the NIH by 40% in 2026. This decision could have an adverse effect on the operations of Bio-Rad. Bio-Rad projects 0.5% revenue growth…
benzinga.com Bio-Rad Laboratories Analysts Raise Their Forecasts After Better-Than-Expected Q2 Earnings Bio-Rad Laboratories, Inc. BIO reported better-than-expected second-quarter financial results on Thursday.
reuters.com Bio-Rad Laboratories beats quarterly profit estimates on strong sales in diagnostics unit Diagnostics firm Bio-Rad Laboratories posted third-quarter profit above Wall Street estimates on Wednesday, helped by a recovery in demand for analytical tools from its biotech clients and steady…
reuters.com Bio-Rad Labs cuts annual revenue forecast on weak demand for diagnostics products Bio-Rad Laboratories cut its annual revenue growth forecast on Thursday, dragged down by weak demand for clinical diagnostics products from biotech clients.
reuters.com Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip Diagnostics firm Bio Rad Laboratories reiterated its 2024 sales growth forecast on Tuesday, weighed by persistently weak spending by biotech companies and sluggish demand in China.
reuters.com Bio-Rad Labs cuts 2023 revenue growth forecast as biotechs cut spending Bio-Rad Laboratories on Thursday lowered its annual revenue growth forecast, given the uncertain pace of the biopharma sector's recovery and ongoing macro challenges, sending the company's shares…